Vir Biotechnology, Inc. is a commercial stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The company leverages its expertise in immunology to provide advanced solutions that aim to tackle the challenges posed by various infectious agents.

Services include:
– Contract development and manufacturing
– Monoclonal antibody production
– Process development
– Quality control and assurance
– Regulatory support

Vir Biotechnology, Inc. stands at the forefront of immunological advancements in the pharmaceutical industry, dedicated to delivering high-quality services to its partners. For further information, please visit vir.bio.